<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-046140</identifier>
<setSpec>0210-4806</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Synchronus bilateral urothelial carcinoma of the upper urinary tract</dc:title>
<dc:description xml:lang="en">Objective: Report a case of a synchronous bilateral urothelial carcinoma of the upper urinary tract        without bladder affectation.        Methods: We describe the diagnosis and treatment of a case of a bilateral upper urothelial carcinoma.        Conclusions: Synchronous bilateral urithelial carcinoma of the upper urinary tract without bladder        affectation in an unusual occurance (1-5% of urothelial tumors) and radical surgery continues to be        the treatment of choice, although it is possible to take a less aggressive approuch with selected        groups of patient, in which we can achiese a survival rate similar to that which we obtain with radical        surgery</dc:description>
<dc:creator>González Enguita, C</dc:creator>
<dc:creator>Gómez, J</dc:creator>
<dc:creator>Bravo Fernández, I</dc:creator>
<dc:creator>Pérez Ortiz, G</dc:creator>
<dc:creator>García Cardoso, J. V</dc:creator>
<dc:creator>Vela Navarrete, R</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: Presentar el caso de un tumor urotelial ureteral bilateral sincrónico sin afectación vesical.        Métodos: Diagnóstico y tratamiento de un caso de tumor urotelial bilateral sincrónico.        Conclusiones: El carcinoma urotelial bilateral sincrónico sin afectación vesical es una entidad rara        (1-5% de todos los tumores uroteliales) donde la cirugía radical sigue siendo el tratamiento curativo        de elección, aunque el mejor conocimiento de esta patología hace que hoy en día se pueda realizar tratamiento        conservador a un grupo seleccionado de pacientes con tasa de similar supervivencia a los        que se le indica tratamiento radical</dc:description>
<dc:source>Actas Urol Esp;30(3): 335-339, mar. 2006. ilus</dc:source>
<dc:identifier>ibc-046140</dc:identifier>
<dc:title xml:lang="es">Carcinoma urotelial ureteral bilateral sincrónico</dc:title>
<dc:subject>^d14915^s22053</dc:subject>
<dc:subject>^d32875^s22053</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d6566^s22027</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:type>article</dc:type>
<dc:date>200603</dc:date>
</metadata>
</record>
</ibecs-document>
